DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage

por Reuvers, Thom G. A., Kanaar, Roland, Nonnekens, Julie
Publicado 2020

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo

por Reuvers, Thom G.A., Verkaik, Nicole S., Stuurman, Debra, de Ridder, Corrina, Groningen, Marian C. Clahsen-van, de Blois, Erik, Nonnekens, Julie
Publicado 2023

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib

por Feijtel, Danny, Reuvers, Thom G. A., van Tuyll-van Serooskerken, Christine, de Ridder, Corrina M. A., Stuurman, Debra C., de Blois, Erik, Verkaik, Nicole S., de Bruijn, Peter, Koolen, Stijn L. W., de Jong, Marion, Nonnekens, Julie
Publicado 2023

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [(177)Lu]Lu-...

por Hooijman, Eline L., Ntihabose, Carolline M., Reuvers, Thom G. A., Nonnekens, Julie, Aalbersberg, Else A., van de Merbel, Jordy R. J. P., Huijmans, Judith E., Koolen, Stijn L. W., Hendrikx, Jeroen J. M. A., de Blois, Erik
Publicado 2022